XLV
ETFHealth Care Select Sector SPDR Fund
State Street · equity
Fund snapshot
The basics: what it costs, how big it is, and how it's moved lately.
+1.5% vs the broad market
Asset mix
63 positions across 3 asset typesTop holdings
Top 10 = 62% of the fund- 1LLYELI LILLY + CO16.11%
- 2JNJJOHNSON + JOHNSON10.72%
- 3ABBVABBVIE INC7.79%
- 4UNHUNITEDHEALTH GROUP INC6.60%
- 5MRKMERCK + CO. INC.5.53%
- 6TMOTHERMO FISHER SCIENTIFIC INC3.65%
- 7AMGNAMGEN INC3.44%
- 8ABTABBOTT LABORATORIES3.01%
- 9GILDGILEAD SCIENCES INC2.79%
- 10PFEPFIZER INC2.41%
Show all 63 positions
- 11CVSCVS HEALTH CORP2.34%
- 12BMYBRISTOL MYERS SQUIBB CO2.16%
- 13DHRDANAHER CORP2.08%
- 14VRTXVERTEX PHARMACEUTICALS INC2.06%
- 15ISRGINTUITIVE SURGICAL INC2.02%
- 16SYKSTRYKER CORP1.89%
- 17MDTMEDTRONIC PLC1.81%
- 18MCKMCKESSON CORP1.70%
- 19ELVELEVANCE HEALTH INC1.41%
- 20CITHE CIGNA GROUP1.30%
- 21REGNREGENERON PHARMACEUTICALS1.12%
- 22BSXBOSTON SCIENTIFIC CORP1.11%
- 23CORCENCORA INC1.02%
- 24HCAHCA HEALTHCARE INC1.00%
- 25CAHCARDINAL HEALTH INC0.91%
- 26EWEDWARDS LIFESCIENCES CORP0.83%
- 27HUMHUMANA INC0.81%
- 28IDXXIDEXX LABORATORIES INC0.73%
- 29BDXBECTON DICKINSON AND CO0.72%
- 30AAGILENT TECHNOLOGIES INC0.68%
- 31WATWATERS CORP0.64%
- 32IQVIQVIA HOLDINGS INC0.59%
- 33ZTSZOETIS INC0.54%
- 34CNCCENTENE CORP0.51%
- 35BIIBBIOGEN INC0.51%
- 36GEHCGE HEALTHCARE TECHNOLOGY0.48%
- 37RMDRESMED INC0.48%
- 38DXCMDEXCOM INC0.47%
- 39VEEVVEEVA SYSTEMS INC CLASS A0.46%
- 40MTDMETTLER TOLEDO INTERNATIONAL0.46%
- 41DGXQUEST DIAGNOSTICS INC0.43%
- 42WSTWEST PHARMACEUTICAL SERVICES0.43%
- 43LHLABCORP HOLDINGS INC0.41%
- 44STESTERIS PLC0.35%
- 45MRNAMODERNA INC0.35%
- 46VTRSVIATRIS INC0.35%
- 47INCYINCYTE CORP0.34%
- 48ZBHZIMMER BIOMET HOLDINGS INC0.30%
- 49COOCOOPER COS INC/THE0.24%
- 50RVTYREVVITY INC0.22%
- 51SOLVSOLVENTUM CORP0.20%
- 52TECHBIO TECHNE CORP0.19%
- 53ALGNALIGN TECHNOLOGY INC0.19%
- 54BAXBAXTER INTERNATIONAL INC0.19%
- 55CRLCHARLES RIVER LABORATORIES0.19%
- 56PODDINSULET CORP0.19%
- 57HSICHENRY SCHEIN INC0.14%
- 58UHSUNIVERSAL HEALTH SERVICES B0.14%
- 59DVADAVITA INC0.13%
- 60SSI US GOV MONEY MARKET CLASS0.11%
- 61IXCU6XAV HEALTH CARE SEP260.01%
- 62US DOLLAR0.00%
- 632602335DCONTRA HOLOGIC INCORPO0.00%
Sector mix
More breakdowns
Company size
Country
Industry
The forces this fund tends to react to: broad economic shifts, leading sectors, and its biggest single names.
Concentration
The top 10 holdings make up 62% of the fund, and the single largest is 16.1%.
Show details
Concentration score (HHI): 606. Higher means more of the fund sits in fewer holdings.
Overlap with another fund
Pick a fund to see how many of the same holdings they share.
Overlap with the broad market
- DIA13% shared · 4 names
- VOO9% shared · 58 names
- VTSAX8% shared · 59 names
- XOVR1% shared · 2 names
- IVV9% shared · 58 names
- FXNAX0% shared · 33 names
- QQQ5% shared · 8 names
- FXAIX8% shared · 58 names
- VFIAX9% shared · 58 names
- FIWGX0% shared · 14 names
- FCTDX3% shared · 58 names
- FCNTX6% shared · 26 names
- FBGRX4% shared · 12 names
- FBALX4% shared · 21 names
- SPY9% shared · 59 names
- VTI8% shared · 59 names
Insight summary
A clear read on this fund, written from the data above.
The Health Care Select Sector SPDR Fund (XLV) is concentrated in 63 holdings, primarily in the health care sector, with a significant focus on pharmaceuticals.
As of July 23, 2026, the fund has an expense ratio of 0.09% and is concentrated, with 62.1% of its assets in its top 10 holdings. It mainly invests in common stocks, with nearly all assets in U.S. companies. The largest industries are pharmaceuticals, biotechnology, and health care equipment. The fund's performance has shown a 20.85% annual return over the past year.
What to watch: Key factors that could influence the fund include the labor market, interest rates, and economic growth.
Data freshness
How current the numbers on this page are.
Holdings as of 2026-07-23.
Holdings as of 2026-07-23 · Prices as of 2026-07-24 · 4 day(s) since last disclosure
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.